Cargando…
Fighting liver fibrosis to reduce mortality associated with chronic liver diseases: The importance of new molecular targets and biomarkers
Autor principal: | Muriel, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413581/ https://www.ncbi.nlm.nih.gov/pubmed/30745133 http://dx.doi.org/10.1016/j.ebiom.2019.02.002 |
Ejemplares similares
-
Clinical importance of laboratory biomarkers in liver fibrosis
por: Aleknavičiūtė-Valienė, Goda, et al.
Publicado: (2022) -
Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
por: Ramos-Tovar, Erika, et al.
Publicado: (2020) -
Interleukin-24 therapy- a potential new strategy against liver fibrosis
por: Petrescu, Anca D., et al.
Publicado: (2021) -
New Research Routes to Fight Myopia
por: González-Méijome, José Manuel
Publicado: (2017) -
Targeting Polyphosphate Kinases in the Fight against Pseudomonas aeruginosa
por: Baijal, Kanchi, et al.
Publicado: (2021)